Plain-English translation of NCT07530809 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a specific eating pattern called 5:2 intermittent fasting can help treat metabolic dysfunction-associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. In this approach, you would eat normally five days a week and eat only about 600 calories (roughly one-quarter of a typical daily amount) on two non-consecutive days. The researchers want to see if this eating pattern can reduce liver fat, improve how your body handles insulin, and reduce inflammation.
Most treatments for fatty liver disease focus on weight loss and healthy eating, but doctors are looking for new dietary approaches that might work better. Recent research suggests that this type of time-restricted eating might help with weight, blood sugar control, and inflammation — all of which affect liver health.
You likely qualify if…
You likely don't qualify if…
After a two-week introduction to healthy eating guidelines, you will be randomly assigned to either try the 5:2 intermittent fasting plan or follow a standard healthy diet without fasting. If you're in the fasting group, on two days per week you'll eat only about 600 calories (typically just breakfast, then fasting until the next morning), and eat normally on the other five days. Throughout the study, you'll have visits to check your liver health, blood work, and other health markers to see how the eating pattern affects your condition.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
Germany